These firms would make great acquisitions for big drug companies looking to expand their cancer portfolios.   Read More

Don’t make your move until then, he says.   Read More

With Amgen dropping after hours and Merck, Celgene and others reporting earnings on Thursday, how should you game health care?   Read More

Cramer makes the call on viewers' favorite stocks.   Read More

Cramer makes the call on viewers' favorite stocks.   Read More

Biotech companies continued their rally today, with the biotech index up more than 35 percent in the last three months. Eric Schmidt, biotech analyst at Cowen, and Joel Sendek, managing director and biotech analyst at Lazard Capital Markets, explained the force behind the comeback and the best stock plays for investors right now.    Read More

Plus, Cramer makes the call on Obama's health-care plans, smartphone data overload and more.   Read More

Today is the 16th annual "Newsmakers in Biotech" event put on by Thomson Reuters and BioCentury.    Read More

Investors were going gaga for Google (GOOG) five years ago today. In one of the most anticipated IPOs over the past decade, the Internet search company priced nearly 20 million shares at $85 per share, raising $1.7 billion dollars through an auction of its shares.    Read More

There’s no offense like a good defense. Find out how to keep your cash, even in the worst of times.   Read More